Éèç€ã®èšåºçããã³è§£ååŠçæ ¹æ
æéŠã®è§£ååŠããã³åºæ¬ç ãªãã®ç»åéç³ãå®çŸãã¹ããè¡éç»åãšä»®æ³3次å ã¢ãã«ã®æåäœçœ®åãããè¡ãã 解ååŠç ç¹åŸŽç¹ã»ç»åäžç¹åŸŽç¹ãèªåçã«æ€åºããããšã§éç³è¡šç€ºãè¡ã£ã.,xç·ctãmriããåæ§æããä»®æ³3 ã»éèç€ ãéæµæ§é£é.è硬å€ã®å䜵çãšããŠã¯ãé£ééèç€ãšèãããéèŠã§ããé£ééèç€ã§ã¯ãéèç€ç Žè£ãäºé²ããåŠçœ®ãšããŠãäžè¬çã«ã¯å èŠé¡ç硬åçæ³ïŒEISïŒãéèç€çµçŽ®è¡ïŒEVLïŒãè¡ãããŸããå€ç§çæ²»çæ³ãšããŠã¯ãé£éé¢æè¡ãšãããµãæè¡ããããŸãã.æŠèŠ. çäŸã¯52æ³,ç·æ§.åŒåžå°é£ã䞻蚎ã«ä»é¢ã«ææ¥æ¬éããã.ç·æ¥æ°ç®¡æ¿ç®¡äžã«CTãæœè¡ãããšãã,å³åŽå€§åèåŒãèªãåŒéšã«æ°ç®¡ãšé£éã®åŸæ¹ã§å·Šæ¹ã«çªåºããæ倧åŸçŽ10cmã®å€§åèç€ãååšã,ãŸã,瞊éå è¡è «ã䌎ã£ãŠãã,ç Žè£ã®å€æã§åœã»ã³ã¿ãŒæ¬éãšããã.éå§ãšé®éäžã«è§£ååŠçæ€èš.èºè¡æ å¡æ çïŒpteïŒã¯çºçããã°æ¥µããŠé節ã§ãç¡æ²»çã§ã¯18ïœ30ïŒ ãæ»äº¡ããã欧米ã«ãããŠã¯ã以åããpteãåŠç£å©Šæ»äº¡çã®ç¬¬1äœãå ããŠãããåŸæ¥ãããåœã«ãããŠpteã¯æ¯èŒçãŸããšãããŠããããè¿å¹Žæ¥éã«å¢å ããæè¿ã¯ããåœã§ãç£ç§çå¡æ ïŒpteãçŸæ°Žå¡æ çãªã©ïŒãåŠç£å©Šæ»äº¡ç.1 2016â2017幎床掻å èºè¡æ å¡æ çããã³æ·±éšéèè¡æ çã®èšºæïŒæ²»çïŒäºé²ã« é¢ããã¬ã€ãã©ã€ã³ïŒ2017幎æ¹èšçïŒ Guidelines for Diagnosis, Treatment and Prevention of Pulmonary Thromboembolism.é²è¡å»ç§å€§åŠæ ¡ç é¢ïŒåŒççææ²¢åžäžŠæš3-2ïŒã®ãå šåœã®å°éå»ãæšèŠããåéã玹ä»ããŸãããã®ä»ã«ãã蚺çç§ç®ã蚺çæéãæ¯èŒçæ··ãŸãªãæéãå®æœããŠããå é²å»çãªã©ã詳ããæ å ±ãæ²èŒããŠããŸãã.éèè¡ã®é¬±åž¯ïŒãã£ããïŒãè¡æ¶²ååºã®äº¢é²ãæ倧ã®åå ãšãªããè¡æµãã£æ»ïŒè¡æ¶²ã®æµããæ»ãããšïŒã®åå ãšããŠã¯é·æéåã姿å¢ã§å± ç¶ããããšããã£è¡ïŒãã£ãã€ïŒæ§å¿äžå šãäžè¢éèç€ã®ååšãæããããã.å°éç®æš 1ïŒå€ç§èšºçã«å¿ èŠãªäžèšã®åºç€çç¥èãç¿çãïŒèšåºå¿çšã§ããïŒ ïŒ1ïŒå±æ解åïŒæè¡ãã¯ãããšããå€ç§èšºçäžã§å¿ èŠãªå±æ解åã«ã€ããŠè¿°ã¹ãããšãã§ããïŒ a ïŒ2ïŒç çåŠïŒå€ç§ç çåŠã®åºç€ãç解ããŠããïŒ a ïŒ3ïŒè «çåŠ â çºçïŒè»¢ç§».ã€ãã§ïŒä»£è¡šçãªéèçŸæ£ïŒããªã ã¡ïŒäžè¢éèç€ïŒäžè¢æ·±éšéèåŒäžå šçïŒæ¥æ§è žéªšã»å€§è ¿éèè¡æ çïŒããã³æ¥æ§èºå¡æ çã«ã€ ããŠïŒç«åŠïŒç æ ïŒæ²»çãªã©ãäžå¿ã«æŠèª¬ããã æåŸã«ïŒè¿å°æ¥ãžã®æ¥æ¬ã®éèåŠã«å¯Ÿããå±æãè¿°ã¹ãã.
ãããšéèç€ã®éã
ãããïŒè¡è¡ååŠçã«å®å®ããçäŸã§evarãéžæããïŒäžå®å®ãªçäŸã§ã¯éè ¹æè¡ãéžæãããåŸåã«ããïŒããã«ïŒè§£ååŠçã«äžæ¢åŽã®ã·ã§ãŒãããã¯ããã³60°以äžã®é«åºŠå±æ²ãã¢ã¯ã»ã¹è¡ç®¡ã现ãçäŸã§ã¯éè ¹æè¡ãéžæããããªã©ïŒæ°å€ãã®ãã€ã¢ã¹.æ ¢æ§éèäžå šã®åé¡. 客芳ceapåœéåé¡ïŒèšåºçç¶ãç å åé¡ã解ååŠçååžãç æ ççåŠçæ©èœé害ïŒã䜿çšããç°ãªãã°ã«ãŒãã®æ£è ã®éèç³»ã®ç¶æ ãè©äŸ¡ããããšãã§ããããã«ããããã«ã1994幎ã«ã¢ã¡ãªã«ã®éèãã©ãŒã©ã 第6å幎次ç·äŒã§g.é£éäžäžéšã«ååšããå€ç«æ§éèç€ (SoV) ããã³æ£åšæ§éèç€ (ScV) ã®æå ãèšåºçæ矩ã«ã€ããŠååãªæ€èšã¯ãªãããŠããªã.ä»åããããã¯, äžéšæ¶å管å èŠé¡æ€æ»ãæœè¡ãã6660äŸäž, SoVããã³ScVãèªãã54äŸ85ç å€ã«ã€ããŠæ€èšãã.SoVã¯36äŸ36ç å€, ScVã¯18äŸ49ç å€, ããŒã åã¯36äŸ53ç å€.解ååŠçè¢äœ UpToDate Contents è窩åèç€ã®æè¡ããã³ æ ¹æ æ³ è§£åããè ç®ç æ»äœã®æ§è³ª éºæã®æ¿è«Ÿ.äžåœé ç²èã®è§£ååŠçæ§é é åœ±è¶ é³æ³¢ã«ãã粟玢éèç€æ£è ã®ç²Ÿå·£å è¡è¡åæ ã®è§£æãšåŸæ¥ã®åé¡åºæºã®æ€èšŒ ãã ãã軜çè ãå«ãŸããŠããç¹å®ä¿å¥çšé£åã®æ ¹æ ãšãªã£ãèšåºç 究ã«ã€ããŠãçµã¿å ¥ããã.çŸä»£å»åŠçéŒçžæ²»çãã«ããããã ãé¢å¿ã®ããæ¹ã¯ãé·å¹Žã«ããããè«žå çããã®æ²»çæç®ããããã«å匷ããŠããŸããããéçžèšåºãå§ããŠ28幎ïŒå¹³æ18幎çŸåšïŒãéããçŸåšãèªåãªãã®éçžæ²»çã確ç«ãã€ã€ããããã«æã£ãã.è¶ é³æ³¢ã«ããé žåèç å€ã®æšæºçè©äŸ¡æ³2016ïŒæ¡ïŒ é žåèè¶ é³æ³¢èšºæã¬ã€ãã©ã€ã³å°å§å¡äŒ å§å¡é· æŸå°Ÿ æ±ïŒæŸå°Ÿã¯ãªããã¯ïŒ å¯å§å¡é· è°·å£ ä¿¡è¡ïŒèªæ²»å»ç§å€§åŠã»èšåºæ€æ»å»åŠïŒ å§å¡ ç³æŽ¥ æºåïŒç波倧åŠã»èšåºæ€æ»å»åŠïŒ.補å e-Anatomy 人äœè§£ååŠ: å»çç»ååŠçãšã€ã©ã¹ã e-Cases å»çç»ååŠçãšæŸå°ç·åŠç çåŠ. 解ååŠçè¢äœ. ã®å§¿å¢ãæããã¡ã§ããã解ååŠã§ã¯åè ãåå€ããŠæã®ã²ããåã«åããç¶æ ãã解ååŠçè¢äœïŒç«äœå§¿å¢ïŒããšåä»ãæ¡çšããŠããŸãã.倧éªåžç«å€§åŠå»åŠéšéå±ç é¢ïŒå€§éªåºå€§éªåžé¿åéåºæçº1-5-7ïŒã®ãå šåœã®å°éå»ãæšèŠããåéã玹ä»ããŸãããã®ä»ã«ãã蚺çç§ç®ã蚺çæéãæ¯èŒçæ··ãŸãªãæéãå®æœããŠããå é²å»çãå°éå€æ¥ãªã©ã詳ããæ å ±ãæ²èŒããŠããŸãã.
Related queries:-> ããšãã§ã®éèç€ã®æ²»ç
è硬å€ã®å䜵çãšããŠã¯ãé£ééèç€ãšèãããéèŠã§ããé£ééèç€ã§ã¯ãéèç€ç Žè£ãäºé²ããåŠçœ®ãšããŠãäžè¬çã«ã¯å èŠé¡ç硬åçæ³ïŒEISïŒãéèç€çµçŽ®è¡ïŒEVLïŒãè¡ãããŸããå€ç§çæ²»çæ³ãšããŠã¯ãé£éé¢æè¡ãšãããµãæè¡ããããŸãã.ççæ§è žçŸæ£ã«ãããè žå 现èå¢ã®å€åããã³ãã®èšåºçæ矩ã解説ãããïŒ2015/9/30ïŒ é£ééèç€ã«å¯ŸããEVLãšEISãäžå¿ãšããå èŠé¡æ²»çã®é²æ©ãšçŸæ³ã«ã€ããŠæŠèª¬ãããïŒ2015/9/30ïŒ æ¬éŠã«ãããBarretté£éçã®ç«åŠãçºçãªã¹ã¯å åã«ã€ããŠè§£èª¬ããã.äž»ã«çŽ°ãéèç€ã«å¯ŸããŠå®æœãããå€æ¥ã§è¡ãããšãã§ããŸããè¡æ¶²ã®éæµã匷ãå Žåã¯ãäžè¬çã«æè¡ãå®æœãããŸããæè¡æ³ãšããŠãéæµãèµ·ãã£ãŠããéèãæå»ããã¹ããªããã³ã°è¡ãéèãçžã£ãŠããŸãé«äœçµçŽ®è¡ããããŸãã.æ·±éšéèè¡æ çæ¥æ§æã«ãããéåçæ³ãå§è¿«çæ³ã«é¢ããŠã¯ãèšåºçéèŠåºŠãèºå¡æ ãžã®ãªã¹ã¯ãç·åè©äŸ¡ããŠæ±ºå®ãã泚ææ·±ã芳å¯ããé¢åºã®æ®µéä»ããèžãã§ããå¿ èŠããããŸãã.Vein of Galen Aneurysmal Malformation (VGAM)ã¯ãå°å ã«ç¹åŸŽçãªãŠããŒã¯ãªåéèå¥åœ¢ã§ãããã ã®çŸæ£ã«é¢ããŠã¯ãçºçåŠçããã³è¡ç®¡è§£ååŠçã«ããããèå¯ãããŠããŠãããLasjauniasãã«ãã£ãŠã ã®æŠå¿µã¯ãŸãšããããŠæç§æžã«ãèšèŒãããŠããã.1ïŒäžè ¿æœ°çã»äžè¢éèç€èšºçã¬ã€ãã©ã€ã³ çå®ã®èæ¯ ã¬ã€ãã©ã€ã³ã¯ïŒãç¹å®ã®èšåºç¶æ³ã«ãããŠïŒé©å㪠å€æãè¡ãããã«ïŒå»çè ãšæ£è ãæ¯æŽããç®çã§ç³» çµ±çã«äœæãããææžãã§ããïŒäžè ¿æœ°çããã®åå .èŠæš:å èŠé¡çã«é£ééèç€ãèªããéèå§äº¢é²ç170äŸ ãéèå€ç§ç 究äŒã®é£ééèç€å èŠé¡å€å®èŠæºã«åºã¥ ãåé¡ã,é èç€ç Žç¶»äºç¥ãšãã®è©äŸ¡ãç®çã«æ€èšãã. æ¶å管åºè¡äŸã¯54äŸ ã§éèç€ç Žç¶»äŸã26äŸ(48.1%),次 ãã§åºè¡æ§èçã18äŸ(33.3%)ãš å€ã.å èŠé¡.éèã®è§£å èšåºçæ矩ãèšåºã§ã®å©çšæ³ãªã©ããŸãšãããéèçŸ. æ£ã«å¯Ÿããè¶ é³æ³¢æ€æ»ã®æŽå²ã¯æ¯èŒçæµ ãã ãèªããããäžè¢éèç€ããã³æ·±éšéèè¡æ çã®è¶ .ããã§ãéèçŸæ£ã«ãããŠæãããèªããããäžè¢éèç€ããã³æ·±éšéèè¡æ çã®è¶ é³æ³¢ syndromeã éèè¡æ åŸéºçïŒã®çºçãè¡æ åçºãèšåºçã«åé¡ãšãªã 5ïŒã CEAP åé¡ã¯èšåºæèŠ(Clinical manifestation)ãç å (Etiologic factors)ã解ååŠç .
-> ufaã§éèç€æè¡ãããå Žæ
1. äžè¢éèç€ã®ç«åŠ. äžè¬çã«äžè¢éèç€ãšèããããçŸæ£ã¯æ¬§ç±³ã§ã¯äººå£ã®çŽ20ïœ60ïŒ ã«èªãããïŒãã®ãã¡æ²»çãå¿ èŠãšãããçç¶ãåããŠãããã®ã¯å šäººå£ã®5ïŒ ã§ïŒéèæ§æœ°çãèªããéçäŸã¯1ïŒ ã§ãããšæšæž¬ãããŠãã.2019幎2æ22æ¥ ãã®æ²»çãæ段ãæçšã»æå¹ã§ãããšæšå¥šããç§åŠçæ ¹æ ãããããåæããªãããŠãã æ²»çè¡ç®¡ã®éåæ§ãèšåºçæåãã¬ã€ãã©ã€ã³ã§ã¯è©äŸ¡ãããã¡ã ããæ£è ã® QOL ãããçã®æå³ã§æ£è èŠç¹ 2.2.4 CT ã¢ã³ã®ãª åçŽããã³çµéèçé 圱å€æäžãçšããåèçžãšéèçžïŒ3 çž è¡åŒã¯ãæ£è ã®ãªã¹ã¯ã解ååŠç.IgMéœæ§åœ¢è³ªçŽ°è浞最ãäž»äœã®å°¿çŽ°ç®¡é質æ§è çæ£è ã®å ç«çµç¹åŠç解æãšèšåºçç¹åŸŽã®æ€èš; 埪ç°åšå ç§. ã«ããŒãã«ã¢ãã¬ãŒã·ã§ã³æ²»çåšè¡æããã³è¡åŸã«ãããçµå£æååºè¬ã¯ã«ãã¡ãªã³ã®æå¹æ§ããã³å®å šæ§è©äŸ¡ã®ããã®åŸãåã芳å¯ç 究.ççµç¹åŠçå®çŸ©ãšåèŽããïŒé£ç¶ããlow density areaãæåºããïŒé£ç¶åçã«ããçµç¹åŠçæ€èšã ãæ¿å®€çµç¯ïŒè²«éæïŒåææïŒå·Šå³èãšç¢ºèªãããã ãŸãå¿å šäœã«æ圱ãããåºæ¿äŒå°ç³»ã®3Dåæ§ç¯å ã«ãããŠã¯èªç±ãªè§åºŠãã粟现ãªå±æ解åãææ¡å¯.ã解ååŠçåºç»ããšãç æ ãã«åºã¥ãçæ žçšåºŠåé¡ïŒä»¥äžPåé¡ïŒè«æã®èšåºçæ矩ãåèå¯ãPåé¡ èšèŒèšå·ãè¿œå ããïŒä»èŠåïŒæ°å€åïŒçè«çå±éã§åŸæ¥ã®èšåºç 究æ¹æ³ãæ€èšããŠïŒçæ žäœç©è«ïŒçæ ž æš¡åãåèã«.äžè¢éèç€ïŒç å ãç çççåŠãçç¶ã城åã蚺æããã³äºåŸã«ã€ããŠã¯MSDããã¥ã¢ã«ïŒãããã§ãã·ã§ãã«çãžã.è ¹éšå€§åèç€ãäžå¿ãšããåèç€ã«å¯ŸããŠã¯ãäžã€ã®æ²»çæ³ã®ã¿ã«åºå·ããããšãªããæ£è ã®ç¶æ ã解ååŠçç¹æ§ã«å¿ããŠãopen surgeryãã¹ãã³ãã°ã©ããæ²»çãé©åã«éžæããŠæ²»çãè¡ã£ãŠãããæè¡æ瞟ãè¯å¥œã§ããã.æ ªåŒäŒç€Ÿæ³ç åè¡ã®ã家åºå»åŠå€§å šç§ããå ã«ããç æ°è§£èª¬ãµã€ãã§ãããæ ¹æ ã«åºã¥ãå»çããæ¹éãšããŠååéã®å°éå»åž«ãäžå¿ã«å·çãç£ä¿®ããã2600é ç®ä»¥äžã®ç æ°è§£èª¬ãšãåœãµã€ãç¬èªã®ãã«ã¹ã±ã¢ãã¥ãŒã¹ãæ²èŒããŠããŸãã.åœé¢ãå蚺ããèéèç€ã«ãããŠãå皮治çã®å¹æãäºåŸãèæ¯å åãæ害äºè±¡ã«ã€ããåŸæ¹èŠçã«æ€èšã解æããã ç 究察象: 1995幎12æ1æ¥ïœ2019幎12æ31æ¥ã«åœé¢ã«ãŠèéèç€ã«å¯ŸããŠå皮治çãè¡ã£ãçäŸïŒã®ã¹çŽ250äŸïŒ 䜿çšããæ å ±.
-> 玫å€ç·ã«ããéèç€æ²»ç
æ·±éšéèè¡æ çãšã¯ã©ã®ãããªç æ°ã§ããïŒ æ·±éšéèè¡æ çïŒDeep Venous ThrombosisïŒä»¥äžDVTïŒã¯ãéèãç¹ã«å€§è ¿éèãªã©ã«è¡æ ãçããçŸæ£ã§ãã足ã®æ·±éšã«ããéèã¯ãè¡æ¶²ãå¿èã«å±ãã倪ããããµããã¯ãã®å€§éèã§ããè¡æ ãåºæ¥ããšããéèå ã®è¡æ¶²ã®æµããéšåçãŸãã¯å®å šã«.ãåŒè·å£«ããããã解説ãïŒ1ïŒå¿è¡ç®¡ç³» å·Šå¿å®€ããæåºãããè¡æ¶²ã¯ãäžè¡å€§åèãšäžè¡å€§åèã«åãããŠå šèº«ã®åèãå·¡ã£ãåŸãå šèº«ã®éèããäžå€§éèãšäžå€§éèã«éçŽããå³å¿æ¿ã«æµå ¥ããïŒäœåŸªç°ïŒãå³å¿æ¿ã«æµå ¥ããè¡æ¶²ã¯æ¬¡ã«å³å¿å®€.ãéèæ§ãã«é¢é£ããè±èªäŸæã®äžèŠ§ãšäœ¿ãæ¹(3ããŒãžç®) - Weblioè±èªäŸææ€çŽ¢.é¡çéèç€é 圱ïŒè¶ é³æ³¢å èŠé¡æ€æ»ãªã©ã§ç¢ºèšºãåæã«äŸã»æè¡è·¯ãææ¡ããŠããïŒãããè¡å蚺æã èŠé¡ç蚺æåã§ããïŒå·šæšå EV ã®èšåºçæ矩ã. ç解ããããã«Â .äºååŠä¿®å 容ããã³äºååŠä¿®æéïŒ ã·ã©ãã¹ã«èšèŒãããŠããåå®ç¿å 容ã確èªããæç§æžã»ã¬ãžã¡ãçšããŠäºååŠ ä¿®ïŒäºç¿ã»åŸ©ç¿ïŒãè¡ããå»çé¢æ¥ã»èšºå¯ãªã©åºæ¬çèšåºæèœå®ç¿ã§ä¿®åŸããææ ã«ã€ããŠå確èªãããããšã.No.10 èå¢ç --解ååŠãªãã³ã«é²å±æ§åŒã®ç¹åŸŽãšèšºçã®çŸæ³ No.11 é£éç --éæµæ§é£éçãäžå¿ã« No.12 ç¥ã£ãŠããã¹ãçŸæ£ --å°å€§è ž No.13 èªå·±å ç«æ§èç 1995幎 Vol.10. No.01 æ©æèçâ蚺çã®çŸæ³.å»çã³ãã¥ãã±ãŒã·ã§ã³åŠåéã§ã¯ãåŸæ¥ã®å€§åŠç é¢å»çæ å ±ãããã¯ãŒã¯ã»ã³ã¿ãŒïŒuminïŒã«ãããæ å ±ã·ã¹ãã ã®æ§ç¯ã»éçšã®ç 究ãç¶ç¶ãã€ã€ãç 究å 容ã®äž»äœã¯ä¿å¥å»çåéã«ãããæ§ã ãªã¬ãã«ã®ã³ãã¥ãã±ãŒã·ã§ã³ã«é¢ããå®èšŒç 究ã«ç§»è¡ããŠããŸãã.Vein of Galen Aneurysmal Malformation (VGAM)ã¯ãå°å ã«ç¹åŸŽçãªãŠããŒã¯ãªåéèå¥åœ¢ã§ãããã ã®çŸæ£ã«é¢ããŠã¯ãçºçåŠçããã³è¡ç®¡è§£ååŠçã«ããããèå¯ãããŠããŠãããLasjauniasãã«ãã£ãŠã ã®æŠå¿µã¯ãŸãšããããŠæç§æžã«ãèšèŒãããŠããã.æ¥æ¬éèåŠäŒJapanese Society of Phlebology. åæµ·éèæ¯æ±éšå°éã«ããçœå®³ã«é¢ããç·æ¥å£°æ ãéèŠã西æ¥æ¬è±ªéšæ°Žå®³ã«ãããéèè¡æ å¡æ çäºé²ã®æŽ»åã«å¯Ÿããå¯éã®ãé¡ã.
-> éèç€ãåç §ããŠãã ãã
1 2016â2017幎床掻å èºè¡æ å¡æ çããã³æ·±éšéèè¡æ çã®èšºæïŒæ²»çïŒäºé²ã« é¢ããã¬ã€ãã©ã€ã³ïŒ2017幎æ¹èšçïŒ Guidelines for Diagnosis, Treatment and Prevention of Pulmonary Thromboembolism.è¡åæ²»çããã³è¡åŸã®è£å©çæ³ãå«ããéåŠçæ²»çã«ãã borderline resectable èµçã®äºåŸã¯æ¹åããå¯èœæ§ã瀺åãããŠãããäžæ¹ããã®åé€ã«ãããŠã¯å¥é¢ã«é£æžãããŸãè¡ç®¡å䜵åé€ãèŠãããªã©é£æ床ã®é«ãããšãå€ããããã«R0ãç®æãã®ã.ãã®èšäºã§ã¯ãæ·±éšéèè¡æ çãã®æŠèŠã»äºé²ã»çŠå¿ãªã©ã«ã€ããŠåããããã解説ããŠããŸããæ·±éšéèè¡æ çã¯ãšã³ãããŒçå矀ãšãåŒã°ããããšããããèºå¡æ ã«ç¹ããããšãããå±éºãªçŸæ£ãšããŠç¥ãããŠããŸããè¡åŸã«çããããšãããããããªãããªïŒçåŠã»äœæ¥çæ³ïŒãçè·åŸäº.13.1. ãªããªã€ãéèå æäžã®å¿é¿ãããããœã³éèå æäžã¯ãã«ãŒããŒã³ã«ã¯è¡ã㪠ã 13.2. çç±ïŒå®éšçããŒã¿ãšèšåºçµéšã®æ ¹æ ãããªã6ãçŸæ®µéã§æå¹æ§ã¯äžæã§ãããš èšããããåŸãªã2ãäžæ¹ã麻é 管çãçŒç管çãè€éã«ãããšãããã¡ãªããã.èŠæš:å èŠé¡çã«é£ééèç€ãèªããéèå§äº¢é²ç170äŸ ãéèå€ç§ç 究äŒã®é£ééèç€å èŠé¡å€å®èŠæºã«åºã¥ ãåé¡ã,é èç€ç Žç¶»äºç¥ãšãã®è©äŸ¡ãç®çã«æ€èšãã. æ¶å管åºè¡äŸã¯54äŸ ã§éèç€ç Žç¶»äŸã26äŸ(48.1%),次 ãã§åºè¡æ§èçã18äŸ(33.3%)ãš å€ã.å èŠé¡.äžè¢éèç€ã¯ïŒè€æ°ã®èšºçç§ã§æ²»çãããŠããçŸæ£. ã§ãããïŒäžè ¿æœ°ç æ¬ã¬ã€ãã©ã€ã³ã®ç®æšã¯ïŒèšåºæ±ºæãæ¯æŽããæš. 奚ããšããã³ã¹ã« ãå å³ããŠåµå·äžè¬ã®è§£èª¬ããã³äžè ¿æœ°çã»äžè¢éè. ç€èšºç C1ïŒè¯è³ªãªæ ¹æ ã¯ãªããïŒéžæè¢ã® 1 ã€ãšããŠæšå¥š. ããïŒè³ªã® 城å C ã 0âŒ6ïŒç å E ã c, p, s, n ã«ïŒè§£ååŠçéšäœ.1ïŒäžè ¿æœ°çã»äžè¢éèç€èšºçã¬ã€ãã©ã€ã³ çå®ã®èæ¯ ã¬ã€ãã©ã€ã³ã¯ïŒãç¹å®ã®èšåºç¶æ³ã«ãããŠïŒé©å㪠å€æãè¡ãããã«ïŒå»çè ãšæ£è ãæ¯æŽããç®çã§ç³» çµ±çã«äœæãããææžãã§ããïŒäžè ¿æœ°çããã®åå .ãå¿ èŠãããïŒèºæ¢å¡ã¯ç çåŠçã«ã¯åºè¡æ§æ¢å¡ã§ããïŒ ã©ã€ã³ã¯ãããŸã§ãçŸæç¹ãŸã§ã®æ å ±ãããšã«äœæãã ããã®ã§ããïŒãããŠèšåºã®åŸªç°åšå ç§å»ãå¿èè¡ç®¡å€ ç§å»ããã³æè¡ã«æºããå€ç§ç³»ã®å»åž«ãïŒéèè¡æ å¡æ .é¡é¢éªšéªšæããã³è»éšçµç¹æå·ïŒé¡é¢ã®èšåºè§£åãç解ãã䞻蚎ãšèšºå¯æèŠãããã®éªšæéšäœãéèŠåšå®ã®æå·éšäœã蚺æãæ²»çæ³ãæ€èšããã â¢: åè£ã»å£èè£ïŒè§£ååŠçç°åžžãç解ããããã«å¯Ÿããæè¡è¡åŒã®çè«ãç¿åŸããã.
-> éèç€çšã©ã³ãã³ã°ãœãã¯ã¹ãè³Œå ¥ãã
解ååŠçè¢äœ UpToDate Contents è窩åèç€ã®æè¡ããã³ æ ¹æ æ³ è§£åããè ç®ç æ»äœã®æ§è³ª éºæã®æ¿è«Ÿ.å°éç®æš 1ïŒå€ç§èšºçã«å¿ èŠãªäžèšã®åºç€çç¥èãç¿çãïŒèšåºå¿çšã§ããïŒ ïŒ3ïŒè «çåŠ â çºçïŒè»¢ç§»åœ¢æããã³TNM åé¡ã«ã€ããŠè¿°ã¹ãããšãã§ããïŒ A â¢äžå¿éèã«ããŒãã«ããã³Swan-Ganz ã«ããŒãã«ã®æ¿å ¥ãšããã«ãã埪ç°ç®¡ç.ç»ååŒçšïŒèºè¡æ å¡æ çããã³æ·±éšéèè¡æ çã®èšºæã æ²»çãäºé²ã«é¢ããã¬ã€ãã©ã€ã³. äœãªã¹ã¯ã®æ¹ã¯ç©æ¥µçéåãšæ©æé¢åºã§okãdvtã¯äžè ¿ã«çºçããããã®ã§ãäºé²ã®ãã足éŠããã¿ãã¿ããŸããããšèª¬æããŸãããã.Knowledge WorkerïŒç¬¬45åæ¥æ¬IVRåŠäŒç·äŒ-ãKnowledge WorkerïŒãã¬ããžã¯ãŒã«ãŒïŒãã¯äžžåéæŸå æ ªåŒäŒç€Ÿãéå¶ãããæ³äººåãæžç±è²©å£²ãµãŒãã¹ã§ããåçš®åéã®å°éæžãåŠè¡æžãäžå¿ã«ãäžžåãªãã§ã¯ã®ãµãŒãã¹ããæäŸããããŸãã.å1 æ£è§£a 95ïŒ ãã®äººãæ£è§£ããŠããã®ã§ã»ãšãã©è§£èª¬ã¯äžèŠã§ãããã解ååŠå³ãç°¡åã«æãåºãã人ã«ã¯äœã®èŠããªãåé¡ã§ãã5%ãµã€ãã«å ¥ã£ãŠããŸã£ã人ã¯ããããæ©ã«ããäžåºŠè§£ååŠå³ãé ã«å©ã蟌ã¿ãŸ ããããèªåãæè¡ãããšãã«ã¯å¿ èŠãªç¥èã§ãããã.ãããïŒè¡è¡ååŠçã«å®å®ããçäŸã§evarãéžæããïŒäžå®å®ãªçäŸã§ã¯éè ¹æè¡ãéžæãããåŸåã«ããïŒããã«ïŒè§£ååŠçã«äžæ¢åŽã®ã·ã§ãŒãããã¯ããã³60°以äžã®é«åºŠå±æ²ãã¢ã¯ã»ã¹è¡ç®¡ã现ãçäŸã§ã¯éè ¹æè¡ãéžæããããªã©ïŒæ°å€ãã®ãã€ã¢ã¹.Off-the-job trainingã泚ç®ãããŠããçŸåšãåæœèšã®å·¥å€«ãç§åŠçæ ¹æ ã«æ ¹ãããå€ç§çãã¬ãŒãã³ã°ã®å°æ¥ã«ã€ããŠè«ãããã è¯è³ªãªå€§åèåŒåœ¢æè¡ã®ããã«ã¯è§£ååŠçããã³æ©èœçã«æ£åžžã«è¿ã倧åèåŒè€åäœãå建ããå¿ èŠããããæªã çºå±éäžã®åé.ã®çŸæ£ã«é¢ããŠã¯ãçºçåŠçããã³è¡ç®¡è§£ååŠçã«ããããèå¯ãããŠã㊠ããŠã¯æ確ã§ããããå®éã®èšåºã§ã¯ãVGAMãªã®ãVGADãªã®ãã®å€æã«è¿·ãå Žå ã³å€§éèãæ¡å€§ããçŸæ£ãã¹ãŠãVGAM (æ¥æ¬èªã§ã¯ã¬ã¬ã³å€§éèç€)ãšåŒãã§ããå Žåãå€ãã ã®ã²ãšã€ãªã£ãŠãããéèéå¡ã«ãããã®çŸæ£ãæ²»çããçè«çæ ¹æ ã«ããªã£ãŠã.æ¥æ¬åŸªç°åšåŠäŒã¯ïŒäž»èŠçŸæ£ã®èšºæããã³æ²»çã«é¢ã ãã¬ã€ãã©ã€ã³ã®äœæã«åãçµãã§ããïŒèºè¡æ å¡æ ç ããã³æ·±éšéèè¡æ çã®èšºæïŒæ²»çïŒäºé²ã«é¢ããã¬ã€ çã«äžå€§éèãã£ã«ã¿ãŒã䜿çšããããïŒæè¿ã§ã¯éæ°ž.
Éèç€ã®èšåºçããã³è§£ååŠçæ ¹æ :
Rating: 189 / 866
Overall: 687 Rates